Once the FDA approved the treatment of the world's priciest drug, the conversation over the cost of "miracle" treatments reignited. But for those who will benefit, there is no debate. In other pharmaceutical news: a look at this year's big bioconference, President Donald Trump's drug pricing agenda, CVS' defense of its Aetna deal, and more.
from Kaiser Health News http://bit.ly/3155Zs3
June 03, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Heart Bypass Surgery Used To Be Considered Risky, But Advances Have Made It Safer And SaferDeaths before being discharged from the hospital are down to between 1 and 3 percent. from Kaiser Health News http://ift.tt/2BP0raS … Read More
Professionals Open Up About Unwritten Rules Regarding Racial Issues In Health WorkplacesDespite many of the nation's hospitals pledging to increase diversity on their boards and in their management ranks and physician workforce, and many installing chief diversity officers to that end, healthcare remains predomi… Read More
Who Needs Romance When You Have Gene Compatibility? New App Matches Users Based On DNAExperts say there isn't much science supporting the idea that you can find a genetically compatible date. In other public health news: cough syrup, medical research, Googling symptoms, back pain, heart health and more. from … Read More
Viewpoints: Short-Term Insurance Is Bad Policy; Limits On Genetic Testing Would Harm Cancer PatientsEditorial pages highlight these health issues and others. from Kaiser Health News http://ift.tt/2BT1Sp5 … Read More
State Highlights: Maryland’s Insurance Model Helped Keep Health Costs Down; California Nurses Closely Watching ‘Fair Share’ Supreme Court CaseMedia outlets report on news from Maryland, California, New York, Wisconsin, Arizona, Florida, Minnesota, Georgia, Michigan, Virginia, Massachusetts and Missouri. from Kaiser Health News http://ift.tt/2orKiRb … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment